Drug Safety, ISoP official journal
Drug Safety is the premier international journal covering the disciplines of pharmacovigilance, pharmacoepidemiology, benefit-risk assessment, risk management and medication error prevention. Drug Safety advances the rational use of pharmacotherapy by publishing reviews and original research articles offering guidance for safe and effective drug utilization and prescribing.
Drug Safety offers a range of additional features designed to increase the visibility, readership and educational value of the journal’s content. Each article is accompanied by a Key Points summary, giving a time-efficient overview of the content to a wide readership. Articles may be accompanied by plain language summaries to assist readers who have some knowledge of, but not in-depth expertise in, the area to understand the scientific content and overall implications of the article. The journal also provides the option to include various types of digital features including animated abstracts, video abstracts, slide decks, audio slides, instructional videos, infographics, podcasts and animations. All additional features are peer reviewed to the same high standard as the article itself. Drug Safety is published by Springer Nature.
Register for TOC / Alerts
Get the table of contents (TOC) of every new issue published in Drug Safety by signing up for alerts on the journal homepage (on the right inside menu).
All ISoP memberships include online access to the full content of Drug Safety.
ISoP editorials are now a regular feature of our associated journal, Drug Safety.
Recent articles include:
New Horizons for ISoP
Guidelines for publication of adverse drug reaction reports in Drug Safety
If ever you submit an adverse drug reaction report to a journal, please respect these recommendations, and cite this paper: Click here for the Guidelines for publication of Adverse Drug Reaction reports.
These are the recommendations of a joint ISoP-ISPE group on the guidelines for the submission and publication of adverse drug reaction reports (2012). The content of this paper represents ISoP position, and not only its authors’.